Watch Dr. Peter Bauer, MD, Chief Scientific Officer at CENTOGENE, as he discusses the genetics of Parkinson’s Disease (PD) and outlines genetic screening options for PD. You will also gain insights into the Rostock International Parkinson’s Disease Study (ROPAD) – a global observational study that is investigating the genetic background of PD patients for better diagnosis and treatment.
- Parkinson’s Disease and genetics of PD
- Genetic screening for an adult-onset disease
- ROPAD: CENTOGENE’s global PD genetic screening program
- Insights from global PD populations
Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Genomic Officer, where he combines […]